For example, vascular damage, cognitive impairment, neurological complications, congenital defects and pregnancy complications A detailed review of these mechanisms is outside the scope of this article
In addition, insulin administration is known to result in increased GST gene expression through the PI3K/AKT/mTOR pathway and reduced intracellular oxidative stress, while glucagon decreases such gene expression
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
Direct Effects on Blood Pressure Blood pressure fluctuations appear in the list of reported effects from BPC-157 users, though this effect shows considerable individual variation